Journal of the American Academy of Dermatology
Volume 61, Issue 4 , Pages 581-591 , October 2009

History of atopy or autoimmunity increases risk of alopecia areata

  • Nazila Barahmani, MD, MS

      Affiliations

    • Department of Dermatology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • Division of Epidemiology and Disease Control, The University of Texas School of Public Health, Houston, Texas
    • Corresponding Author InformationCorrespondence to: Nazila Barahmani, MD, MS, Department of Dermatology, The University of Texas M. D. Anderson Cancer Center, 1400 Pressler, Unit 1452, Houston, TX 77030.
    • ,
  • Matthew B. Schabath, PhD

      Affiliations

    • Division of Epidemiology and Disease Control, The University of Texas School of Public Health, Houston, Texas
    • Division of Cancer Prevention and Control, The H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
    • ,
  • Madeleine Duvic, MD

      Affiliations

    • Department of Dermatology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • National Alopecia Areata Registry

,Accepted 3 April 2009.

References 

  1. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ. Incidence of alopecia areata in Olmsted County, Minnesota, 1975-1989. Mayo Clin Proc. 1995;70:628–633
  2. Sundberg JP, Boggess D, Silva KA, McElwee KJ, King LE, Li R, et al. Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol. 2003;120:771–775
  3. Martinez-Mir A, Zlotogorski A, Gordon D, Petukhova L, Mo J, Gilliam TC, et al. Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet. 2007;80:316–328
  4. Jackow C, Puffer N, Hordinsky M, Nelson J, Tarrand J, Duvic M. Alopecia areata and cytomegalovirus infection in twins: genes versus environment. J Am Acad Dermatol. 1998;38:418–425
  5. McDonagh AJ, Tazi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin Exp Dermatol. 2002;27:405–409
  6. Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol. 2006;20:1055–1060
  7. Ikeda T. A new classification of alopecia areata. Dermatologica. 1965;31:421–445
  8. Tan E, Tay YK, Goh CL, Chin Giam Y. The pattern and profile of alopecia areata in Singapore–a study of 219 Asians. Int J Dermatol. 2002;41:748–753
  9. Xiao FL, Yang S, Liu JB, He PP, Yang J, Cui Y, et al. The epidemiology of childhood alopecia areata in China: a study of 226 patients. Pediatr Dermatol. 2006;23:13–18
  10. Nanda A, Al-Foruzan AS, Al-Hasawi F. Alopecia areata in children: a clinical profile. Pediatr Dermatol. 2002;19:482–485
  11. Wang SJ, Shohat T, Vadheim C, Shellow W, Edwards J, Rotter JI. Increased risk for type I (insulin-dependent) diabetes in relatives of patients with alopecia areata (AA). Am J Med Genet. 1994;51:234–239
  12. Barahmani N, Zhang Q, Hordinsky M, Price V, Christiano A, Norris D, et al. Increased incidence of self-reported autoimmunity and atopy in alopecia areata: 67th annual meeting of the Society for Investigative Dermatology. [abstract] J Invest Dermatol. 2006;126:S101
  13. Duvic M, Norris D, Christiano A, Hordinsky M, Price V. Alopecia areata registry: an overview. J Investig Dermatol Symp Proc. 2003;8:219–221
  14. Lugogo NL, Kraft M. Epidemiology of asthma. Clin Chest Med. 2006;27:1–15
  15. Hanifin JM, Reed ML. Eczema Prevalence and Impact Working Group. A population-based survey of eczema prevalence in the United States. Dermatitis. 2007;18:82–91
  16. Nathan R, Meltzer E, Derebery J, Stang P, Corrao M, Allern G, et al. Prevalence of nasal symptoms in the Unites States: findings from burden of allergic rhinitis in America survey. J Allergy Clin Immunol. 2008;121:S208–S209
  17. Ahmed I, Nasreen S, Bhatti R. Alopecia areata in children. J Coll Physicians Surg Pak. 2007;17:587–590
  18. Sharma VK, Kumar B, Dawn G. A clinical study of childhood alopecia areata in Chandigarh, India. Pediatr Dermatol. 1996;13:372–377
  19. Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest. 2007;117:2019–2027
  20. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest. 1998;101:62–67
  21. Barahmani N, Whaley K, Duvic M. Alopecia areata after allogeneic bone marrow transplantation from an affected, human leukocyte antigen-matched sibling. J Am Acad Dermatol. 2003;49:1192
  22. Tobin DJ. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Investig Dermatol Symp Proc. 2003;8:176–181
  23. Paus R, Slominski A, Czarnetzki BM. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?. Yale J Biol Med. 1993;66:541–554
  24. McElwee KJ, Hoffmann R. Alopecia areata–animal models. Clin Exp Dermatol. 2002;27:410–417
  25. Ahmed AM, Barahmani N, Duvic M. National Alopecia Areata Registry. Familial alopecia areata and chronic thrombocytopenia. J Am Acad Dermatol. 2008;58(Suppl):S75–S77
  26. Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet. 2000;66:1833–1844
  27. Duvic M, Hordinsky MK, Fiedler VC, O'Brien WR, Young R, Reveille JD. HLA-D locus associations in alopecia areata: DRw52A may confer disease resistance. Arch Dermatol. 1991;127:64–68
  28. Welsh EA, Clark HH, Epstein SZ, Reveille JD, Duvic M. Human leukocyte antigen-DQB01∗03 alleles are associated with alopecia areata. J Invest Dermatol. 1994;103:758–763
  29. Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD. HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol. 1995;33:757–764
  30. Barahmani N, de Andrade M, Slusser JP, Wei Q, Hordinsky M, Price VH, et al. Human leukocyte antigen class II alleles are associated with risk of alopecia areata. J Invest Dermatol. 2008;28:240–243
  31. Saeki H, Kuwata S, Nakagawa H, Etoh T, Yanagisawa M, Miyamoto M, et al. Analysis of disease-associated amino acid epitopes on HLA class II molecules in atopic dermatitis. J Allergy Clin Immunol. 1995;96:1061–1068
  32. Rekha PL, Vijayalakshmi V, Shilpa SR, Vinod P, Ishaq M. Association of HLA-DQB1∗ and HLA-DRB1∗ alleles with goitrous juvenile autoimmune hypothyroidism–a case control study. J Clin Immunol. 2007;27:486–489
  33. Zeitlin AA, Heward JM, Newby PR, Carr-Smith JD, Franklyn JA, Gough SC, et al. Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease. Genes Immun. 2008;9:358–363
  34. McElwee KJ, Tobin DJ, Bystryn JC, King LE, Sundberg JP. Alopecia areata: an autoimmune disease?. Exp Dermatol. 1999;8:371–379
  35. Misery L, Sannier K, Chastaing M, Le Gallic G. Treatment of alopecia areata with sulfasalazine. J Eur Acad Dermatol Venereol. 2007;21:547–548
  36. Bui K, Polisetty S, Gilchrist H, Jackson SM, Frederic J. Successful treatment of alopecia universalis with alefacept: a case report and review of the literature. Cutis. 2008;81:431–434
  37. Borish L, Rosenwasser LJ. Cytokines in allergic inflammation. In:  Adkinson NF,  Yunginger JW,  Busse WW,  Bochner BS,  Holgate ST,  Simons FER editor. Middleton's allergy: principles and practice. Philadelphia: Mosby; 2003;p. 135–157
  38. Przybilla B, Ring J, Völk M. Total IgE levels in the serum in dermatologic diseases. Hautarzt. 1986;37:77–82
  39. Elston DM, McCollough ML, Bergfeld WF, Liranzo MO, Heibel M. Eosinophils in fibrous tracts and near hair bulbs: a helpful diagnostic feature of alopecia areata. J Am Acad Dermatol. 1997;37:101–106
  40. El Darouti M, Marzouk SA, Sharawi E. Eosinophils in fibrous tracts and near hair bulbs: a helpful diagnostic feature of alopecia areata. J Am Acad Dermatol. 2000;42:305–307
  41. Allam JP, Novak N. The pathophysiology of atopic eczema. Clin Exp Dermatol. 2006;31:89–93
  42. Teraki Y, Imanishi K, Shiohara T. Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis). Acta Derm Venereol. 1996;76:421–423
  43. Jutel M, Klunker S, Akdis M, Malolepszy J, Thomet OA, Zak-Nejmark T, et al. Histamine upregulates Th1 and dowregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression. Int Arch Allergy Immunol. 2001;124:190–192
  44. Ogg G. Role of T cells in the pathogenesis of atopic dermatitis. Clin Exp Allergy. 2009;39:310–316
  45. Jung T, Stingl G. Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights. J Allergy Clin Immunol. 2008;122:1074–1081
  46. Barahmani N, Lopez A, Babu D, Hernandez M, Donely SE, Duvic M. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy. Clin Exp Dermatol. doi:10.1111/j.1365-2230.2009.03523.x. In press.
  47. King K, Poster AM, Nedorost ST, Stevens SR, Cooper KD. Atopic dermatitis. In:  Bolognia JL,  Jorizzo JL,  Rapini RP editor. Dermatology. New York: Mosby; 2003;p. 199–214
  48. Bußmann C, Bieber T, Novak N. Systemic therapeutic options for severe atopic dermatitis. J Dtsch Dermatol Ges. 2009;7:205–219
  49. Altrichter S, Kriehuber E, Moser J, Valenta R, Kopp T, Stingl G. Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis. J Invest Dermatol. 2008;128:2232–2239
  50. Mittermann I, Aichberger KJ, Bünder R, Mothes N, Renz H, Valenta R. Autoimmunity and atopic dermatitis. Curr Opin Allergy Clin Immunol. 2004;4:367–371
  51. Rabin RL, Levinson AI. The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature. Clin Exp Immunol. 2008;153:19–30

 Principal investigators of National Alopecia Areata Registry: Hordinsky M, Christiano A, Price VH, Norris D, and Duvic M.

 Supported by the National Alopecia Areata Registry (NAAR), a National Institute of Arthritis and Musculoskeletal and Skin Diseases contract NO1-AR-6-2279, and National Alopecia Areata Foundation (NAAF).

 Conflicts of interest: None declared.

 Reprints not available from the authors.

PII: S0190-9622(09)00518-0

doi: 10.1016/j.jaad.2009.04.031

Journal of the American Academy of Dermatology
Volume 61, Issue 4 , Pages 581-591 , October 2009

Article Tools

* Image Usage & Resolution